nti_article_05

Leversense

Leversense is commercializing an innovative new method for in vitro diagnostics technology. The technology, licensed from Drexel University, is a solid-state electromechanical sensor technology used to detect protein, nucleic acid and pathogen disease indicators. Ben Franklin Technology Partners of Southeastern PA has also invested $500,000 in the company.

www.leversense.com

Nanotechnology Commercialization in Pennsylvania

“Across the world, the competition to find the next great scientific advancement continues to grow… as  a competitor in the global marketplace, it is Pennsylvania’s responsibility to give our universities, companies and partners the best opportunties to be on the forefront of these advancements.”

–The Honorable Edward G. Rendell
Governor of Pennsylvania